The distance between the edges of the wound were measured at ten different areas from the wound edge to edge using Spot software
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
Melasma: Melasma, also known as Chloasma, is a common skin condition characterised by dark patches on the skin
BPC-157 Injection Benefits The superiority of BPC-157 injections over capsules is that it provides instant, local effects on the injection site
Calibration of the instrument was achieved using Pierce LTQ ESI Positive (#88323
Nguyen, G